Bg pattern

NUVAXOVID JN.1 INJECTABLE DISPERSION

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NUVAXOVID JN.1 INJECTABLE DISPERSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Nuvaxovid JN.1 injectable suspension

Vaccine against COVID-19 (recombinant, with adjuvant)

This medicine is subject to additional monitoring, which will allow for the quick identification of new safety information. You can help by reporting any side effects you may get. The last section of section 4 will tell you how to report side effects.

Read all of this leaflet carefully before you receive this vaccine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet

  1. What is Nuvaxovid JN.1 and what is it used for
  2. What you need to know before you receive Nuvaxovid JN.1
  3. How to use Nuvaxovid JN.1
  4. Possible side effects
  5. Storage of Nuvaxovid JN.1
  6. Contents of the pack and other information

1. What is Nuvaxovid JN.1 and what is it used for

Nuvaxovid JN.1 is a vaccine to prevent COVID-19 caused by the SARS-CoV-2 virus.

Nuvaxovid JN.1 is given to people from 12 years of age.

The vaccine makes the immune system (the body's natural defenses) produce antibodies and specialized white blood cells that act against the virus to provide protection against COVID-19. None of the components of this vaccine can cause COVID-19.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you receive Nuvaxovid JN.1

Nuvaxovid JN.1 must not be given

  • if you are allergic to the active substance or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before you are given Nuvaxovid JN.1 if:

  • you have ever had a severe or potentially life-threatening allergic reaction after receiving any injection of a vaccine or after you were given Nuvaxovid or Nuvaxovid JN.1 in the past,
  • you have ever fainted after an injection with a needle, have a high fever (over 38°C) or a severe infection. However, you can receive the vaccine if you have a mild fever or an upper respiratory tract infection, such as a cold,
  • you have bleeding problems, bruise easily, or take a medicine to prevent blood clots,
  • your immune system does not work properly (immunodeficiency) or you are taking medicines that weaken the immune system (such as high doses of corticosteroids, immunosuppressants, or anticancer medicines).

There is a higher risk of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the membrane surrounding the heart) after vaccination with Nuvaxovid, see section 4. These disorders can occur a few days after vaccination and have mainly occurred within 14 days.

After vaccination, you should be alert to the signs of myocarditis and pericarditis, such as difficulty breathing, palpitations, and chest pain, and should seek immediate medical attention if they occur.

If you are in any of the above situations (or are unsure), talk to your doctor, pharmacist, or nurse before you are given Nuvaxovid JN.1.

As with any vaccine, it is possible that a single dose of Nuvaxovid JN.1 may not protect all those who receive it, and it is not known for how long you will be protected.

Children

Nuvaxovid JN.1 is not recommended for children under 12 years of age. There is currently no information available on the use of Nuvaxovid JN.1 in children under 12 years of age.

Other medicines and Nuvaxovid JN.1

Tell your doctor, nurse, or pharmacist if you are taking, have recently taken, or might take any other medicines or vaccines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor, pharmacist, or nurse for advice before you receive this vaccine.

Driving and using machines

Some of the side effects of Nuvaxovid JN.1 listed in section 4 (Possible side effects) may temporarily affect your ability to drive or use machines (such as feeling faint or dizzy or feeling very tired).

Do not drive or use machines if you feel unwell after vaccination. Wait until the effects of the vaccine have worn off before driving or using machines.

Nuvaxovid JN.1 contains sodium and potassium

This vaccine contains less than 1 mmol of sodium (23 mg) per dose; this is essentially "sodium-free".

This vaccine contains less than 1 mmol of potassium (39 milligrams) per dose; this is essentially "potassium-free".

3. How to use Nuvaxovid JN.1

People from 12 years of age

Nuvaxovid JN.1 will be given as a single injection of 0.5 ml.

If you have previously received a COVID-19 vaccine, Nuvaxovid JN.1 should be given at least 3 months after the most recent dose of a COVID-19 vaccine.

Your doctor, pharmacist, or nurse will inject the vaccine into a muscle, usually in the upper arm.

During and after each injection of the vaccine, the doctor, pharmacist, or nurse will observe you for about 15 minutes to detect signs of an allergic reaction.

Additional doses (0.5 ml) of Nuvaxovid JN.1 may be given at the discretion of the healthcare professional, taking into account your clinical conditions in accordance with national recommendations.

People with weakened immune systems

If your immune system does not work properly, you may receive additional doses in accordance with national recommendations.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this vaccine can cause side effects, although not everybody gets them. Most side effects go away a few days after they appear. If your symptoms persist, contact your doctor, pharmacist, or nurse.

As with other vaccines, you may feel pain or discomfort at the injection site, or you may experience some redness and swelling at the site. However, these reactions usually go away within a few days.

Get urgent medical attention if you have any of the following signs and symptoms of an allergic reaction:

  • feeling faint or dizzy
  • changes in heartbeats
  • shortness of breath
  • wheezing
  • swelling of the lips, face, or throat
  • rash or skin eruption
  • nausea or vomiting
  • stomach pain

Talk to your doctor or nurse if you experience any other side effect. These may include:

Very common(may affect more than 1 in 10 people):

  • headache
  • feeling sick (nausea) and being sick (vomiting)
  • muscle pain
  • joint pain
  • tenderness or pain at the injection site
  • feeling very tired (fatigue)
  • feeling unwell

Common(may affect up to 1 in 10 people):

  • redness at the injection site
  • swelling at the injection site
  • fever (over 38°C)
  • pain or discomfort in the arm, hand, leg, and/or foot (pain in the limbs)

Uncommon(may affect up to 1 in 100 people):

  • enlarged lymph nodes
  • high blood pressure
  • itching of the skin, skin rash, or hives
  • redness of the skin
  • itching at the injection site
  • chills

Rare(may affect up to 1 in 1,000 people):

  • heat at the injection site

Frequency not known(cannot be estimated from the available data):

  • severe allergic reaction
  • unusual sensation in the skin, such as tingling or prickling (paresthesia)
  • decreased sensitivity, especially in the skin (hypoesthesia)
  • inflammation of the heart muscle (myocarditis) or inflammation of the membrane surrounding the heart (pericarditis), which can lead to difficulty breathing, palpitations, or chest pain

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V and include the batch number, if available. By reporting side effects, you can help provide more information on the safety of this vaccine.

5. Storage of Nuvaxovid JN.1

Keep this medicine out of the sight and reach of children.

Your doctor, pharmacist, or nurse is responsible for storing this vaccine and disposing of any unused product properly.

Information on storage, expiry date, use, and handling is described in the section for healthcare professionals at the end of the leaflet.

6. Contents of the pack and other information

Composition of Nuvaxovid JN.1

  • One dose (0.5 ml) of Nuvaxovid JN.1 contains 5 micrograms of SARS-CoV-2 spike protein (omicron JN.1)* and the adjuvant Matrix-M.

*produced using recombinant DNA technology using a baculovirus expression system in an insect cell line derived from Sf9 cells of the species Spodoptera Frugiperda.

  • Matrix-M is included in this vaccine as an adjuvant. Adjuvants are substances included in certain vaccines to accelerate, improve, or prolong the protective effects of the vaccine. The adjuvant Matrix-M contains fraction-A (42.5 micrograms) and fraction-C (7.5 micrograms) of Quillaja saponaria Molina extract per 0.5 ml dose.
  • The other ingredients (excipients) included in Nuvaxovid JN.1 are:
  • disodium hydrogen phosphate heptahydrate
  • sodium dihydrogen phosphate monohydrate
  • disodium phosphate dihydrate
  • sodium chloride
  • polysorbate 80
  • cholesterol
  • phosphatidylcholine (including all-rac-α-tocopherol)
  • potassium dihydrogen phosphate
  • potassium chloride
  • sodium hydroxide (for pH adjustment)
  • hydrochloric acid (for pH adjustment)
  • water for injections

Appearance of Nuvaxovid JN.1 and pack contents

  • The suspension is colorless to slightly yellow, transparent to slightly opalescent (pH 7.2).
  • 0.5 ml of injectable suspension in a vial with a rubber stopper and a removable blue cap.
  • Pack size: 1 single-dose vial or 10 single-dose vials. Each vial contains 1 dose of 0.5 ml.

Marketing authorization holder

Novavax CZ a.s.

Líbalova 2348/1, Chodov

149 00 Praha 4

Czechia

Manufacturer

Novavax CZ a.s.

Bohumil 138

Jevany, 28163

Czechia

You can request more information about this medicine from the local representative of the marketing authorization holder:

Spain

sanofi-aventis, S.A.

Tel: +34 93 485 94 00

France

Sanofi Winthrop Industrie

Tel: +33 800 222 555

Call from abroad: +33 1 57 63 23 23

BE, BG, CZ, DK, DE, EE, GR, HR, IE, IS, IT, CY, LV, LT, LU, HU, MT, NL, NO, AT, PL, PT, RO, SI, SK, FI, SE:

Novavax CZ a.s.

Tel: +353 1 513 6137

Date of last revision of this leaflet:

Scan the code with a mobile device to get the leaflet in different languages.

Square black and white QR code with visible internal modules and patterns

Or visit the URL: https://www.NovavaxCovidVaccine.com

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency website: https://www.ema.europa.eu

The leaflet can be found in all languages of the European Union/European Economic Area on the European Medicines Agency website.

-------------------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Administer Nuvaxovid JN.1 by intramuscular injection, preferably in the deltoid muscle of the upper arm, as a single dose.

In people who have previously received a COVID-19 vaccine, Nuvaxovid JN.1 should be given at least 3 months after the most recent dose of a COVID-19 vaccine.

Additional doses may be given to people with severe immunosuppression, in accordance with national recommendations.

Traceability

In order to improve the traceability of biological medicinal products, the name and batch number of the administered product should be clearly recorded.

Instructions for handling and administration

Do not use this vaccine after the expiry date which is stated on the label and carton after EXP. The expiry date is the last day of the month shown.

This vaccine should be handled by a healthcare professional using aseptic techniques to ensure the sterility of each dose.

Preparation for use

  • The vaccine is supplied ready for use.
  • The unopened vaccine should be stored in a refrigerator (between 2°C and 8°C) and kept in the outer packaging to protect it from light.
  • Immediately before use, remove the vaccine vial from the carton in the refrigerator.
  • Discard the vial and any excess volume after extraction and administration of a dose.

Inspect the vial

  • Gently move the vial before extracting the dose. Do not shake it.
  • Each vial contains a suspension that is colorless to slightly yellow, transparent to slightly opalescent.
  • Visually inspect the contents of the vial for visible particles and/or discoloration before administration. Do not administer the vaccine if you detect any.

Administer the vaccine

  • An overfill is included per vial to ensure that a single 0.5 ml dose can be extracted from the single-dose vial.
  • A 0.5 ml dose is extracted into a sterile needle and syringe for intramuscular injection, preferably in the deltoid muscle of the upper arm.
  • Do not mix the vaccine in the same syringe with other vaccines or medicinal products.

Discard

  • Discard the vial and any excess volume after extraction and administration of a dose.

Disposal

Disposal of the unused product and all materials that have come into contact with it should be done in accordance with local regulations.

Online doctors for NUVAXOVID JN.1 INJECTABLE DISPERSION

Discuss questions about NUVAXOVID JN.1 INJECTABLE DISPERSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (18)
Doctor

Antonio Cayatte

General medicine 44 years exp.

Dr Antonio Cayatte is a physician in General and Acute Medicine with over 30 years of experience across clinical care, medical research, and education. He offers online consultations for adults with a wide range of symptoms, both acute and chronic. His clinical background includes: 

  • assessment of sudden or unclear symptoms
  • ongoing care for chronic conditions
  • follow-up after hospital discharge
  • interpretation of test results
  • medical support while abroad

Dr Cayatte earned his degree from the University of Lisbon and taught internal medicine at Boston University School of Medicine. He holds active medical registrations in both Portugal and the UK and is a Fellow of the American Heart Association. Consultations are available in English and Portuguese. Patients value his clarity, professionalism, and balanced approach to evidence-based care.

Dr. Antonio Cayatte provides comprehensive care for a broad spectrum of common health concerns, including:

  • Respiratory & ENT: acute bronchitis, concerns related to pneumonia, sinusitis, tonsillitis, ear infections, sore throat conditions, and allergic rhinitis
  • Eye Health: allergic and infectious conjunctivitis, as well as red or irritated eyes
  • Digestive & Urinary: gastroesophageal reflux disease (GERD), gastritis, urinary tract infections, and cystitis
  • Chronic Conditions: hypertension, elevated cholesterol, and structured weight management planning
5.0 (199)
Doctor

Taisiia Proida

Family medicine 7 years exp.

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

5.0 (940)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€66
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€86

Get NUVAXOVID JN.1 INJECTABLE DISPERSION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for NUVAXOVID JN.1 INJECTABLE DISPERSION?

NUVAXOVID JN.1 INJECTABLE DISPERSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in NUVAXOVID JN.1 INJECTABLE DISPERSION?

The active ingredient in NUVAXOVID JN.1 INJECTABLE DISPERSION is covid-19, protein subunit. This information helps identify medicines with the same composition but different brand names.

Who manufactures NUVAXOVID JN.1 INJECTABLE DISPERSION?

NUVAXOVID JN.1 INJECTABLE DISPERSION is manufactured by Novavax Cz A.S.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of NUVAXOVID JN.1 INJECTABLE DISPERSION online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether NUVAXOVID JN.1 INJECTABLE DISPERSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy NUVAXOVID JN.1 INJECTABLE DISPERSION in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy NUVAXOVID JN.1 INJECTABLE DISPERSION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to NUVAXOVID JN.1 INJECTABLE DISPERSION?

Other medicines with the same active substance (covid-19, protein subunit) include BIMERVAX EMULSION FOR INJECTION, NUVAXOVID Injectable Dispersion, NUVAXOVID XBB.1.5 INJECTABLE DISPERSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media